BioCurex Inc. and Abbott Laboratories Jointly Present RECAF Results At International Cancer Congress
RICHMOND, British Columbia, Sept. 20, 2007 (PRIME NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) today announced the acceptance of two presentations submitted to the International Society for Oncodevelopmental Biology and Medicine (ISOBM). The presentations document two RECAF studies involving joint initiatives with the University of Munich, Germany and Abbott.